Literature DB >> 23883233

Imaging tumor angiogenesis: the road to clinical utility.

Andrei Iagaru1, Sanjiv Sam Gambhir.   

Abstract

OBJECTIVE: Tumor growth and progression require the formation of new blood vessels from preexisting vasculature, a process called angiogenesis. The ability to noninvasively visualize angiogenesis may provide new opportunities to more appropriately select patients for antiangiogenesis treatment and to monitor treatment efficacy.
CONCLUSION: The superior molecular sensitivity of PET and the lack of radiation from MRI and contrast-enhanced ultrasound put these techniques at the forefront of clinical translation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23883233     DOI: 10.2214/AJR.12.8568

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  24 in total

Review 1.  Lung and Abdominal Biopsies in the Age of Precision Medicine.

Authors:  Leonard Dalag; Jonathan K Fergus; Steven M Zangan
Journal:  Semin Intervent Radiol       Date:  2019-08-19       Impact factor: 1.513

2.  The Distribution Volume of 18F-Albumin as a Potential Biomarker of Antiangiogenic Treatment Efficacy.

Authors:  Jyoti Roy; Frank Kuo; Falguni Basuli; Mark R Williams; Karen Wong; Michael V Green; Jurgen Seidel; Stephen S Adler; Biying Xu; Peter L Choyke; Elaine M Jagoda
Journal:  Cancer Biother Radiopharm       Date:  2019-02-15       Impact factor: 3.099

3.  MRI-CEST assessment of tumour perfusion using X-ray iodinated agents: comparison with a conventional Gd-based agent.

Authors:  Annasofia Anemone; Lorena Consolino; Dario Livio Longo
Journal:  Eur Radiol       Date:  2016-08-29       Impact factor: 5.315

4.  pH-controlled gas-generating mineralized nanoparticles: a theranostic agent for ultrasound imaging and therapy of cancers.

Authors:  Kyung Hyun Min; Hyun Su Min; Hong Jae Lee; Dong Jin Park; Ji Young Yhee; Kwangmeyung Kim; Ick Chan Kwon; Seo Young Jeong; Oscar F Silvestre; Xiaoyuan Chen; Yu-Shik Hwang; Eun-Cheol Kim; Sang Cheon Lee
Journal:  ACS Nano       Date:  2015-01-08       Impact factor: 15.881

5.  OKN-007 decreases VEGFR-2 levels in a preclinical GL261 mouse glioma model.

Authors:  Patricia Coutinho de Souza; Nataliya Smith; Richard Pody; Ting He; Charity Njoku; Robert Silasi-Mansat; Florea Lupu; Bill Meek; Hong Chen; Yunzhou Dong; Debra Saunders; Albert Orock; Erik Hodges; Sarah Colijn; Nadezda Mamedova; Rheal A Towner
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-06-15

Review 6.  Molecular imaging of the tumor microenvironment for precision medicine and theranostics.

Authors:  Marie-France Penet; Balaji Krishnamachary; Zhihang Chen; Jiefu Jin; Zaver M Bhujwalla
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

7.  PET molecular imaging of angiogenesis with a multiple tyrosine kinase receptor-targeted agent in a rat model of myocardial infarction.

Authors:  Samar Dissoki; Galith Abourbeh; Olga Salnikov; Eyal Mishani; Orit Jacobson
Journal:  Mol Imaging Biol       Date:  2015-04       Impact factor: 3.488

8.  68Ga-Chelation and comparative evaluation of N,N'-bis-[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N'-diacetic acid (HBED-CC) conjugated NGR and RGD peptides as tumor targeted molecular imaging probes.

Authors:  Drishty Satpati; Rohit Sharma; Chandan Kumar; Haladhar Dev Sarma; Ashutosh Dash
Journal:  Medchemcomm       Date:  2017-02-16       Impact factor: 3.597

9.  Photoacoustic imaging for the evaluation of early tumor response to antivascular treatment.

Authors:  Jun Yang; Guang Zhang; Qinqing Li; Chengde Liao; Lin Huang; Tengfei Ke; Huabei Jiang; Dan Han
Journal:  Quant Imaging Med Surg       Date:  2019-02

Review 10.  Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3.

Authors:  Haojun Chen; Gang Niu; Hua Wu; Xiaoyuan Chen
Journal:  Theranostics       Date:  2016-01-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.